nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Paraesthesia—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Thrombocytopenia—Etoposide—testicular cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Dyspnoea—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Skin disorder—Etoposide—testicular cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Hyperhidrosis—Etoposide—testicular cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—testicular cancer	0.000991	0.000991	CcSEcCtD
Naratriptan—Diarrhoea—Dactinomycin—testicular cancer	0.000988	0.000988	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—testicular cancer	0.000987	0.000987	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000985	0.000985	CcSEcCtD
Naratriptan—Vomiting—Bleomycin—testicular cancer	0.000985	0.000985	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—testicular cancer	0.000982	0.000982	CcSEcCtD
Naratriptan—Depression—Methotrexate—testicular cancer	0.000979	0.000979	CcSEcCtD
Naratriptan—Hypotension—Etoposide—testicular cancer	0.000977	0.000977	CcSEcCtD
Naratriptan—Rash—Bleomycin—testicular cancer	0.000976	0.000976	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—testicular cancer	0.000976	0.000976	CcSEcCtD
Naratriptan—Pain—Cisplatin—testicular cancer	0.000976	0.000976	CcSEcCtD
Naratriptan—Dermatitis—Bleomycin—testicular cancer	0.000975	0.000975	CcSEcCtD
Naratriptan—Hypersensitivity—Ifosfamide—testicular cancer	0.000975	0.000975	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—testicular cancer	0.000953	0.000953	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—testicular cancer	0.000952	0.000952	CcSEcCtD
Naratriptan—Asthenia—Ifosfamide—testicular cancer	0.000949	0.000949	CcSEcCtD
Naratriptan—Sweating—Methotrexate—testicular cancer	0.000941	0.000941	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—testicular cancer	0.00094	0.00094	CcSEcCtD
Naratriptan—Feeling abnormal—Cisplatin—testicular cancer	0.00094	0.00094	CcSEcCtD
Naratriptan—Paraesthesia—Etoposide—testicular cancer	0.000939	0.000939	CcSEcCtD
Naratriptan—Pruritus—Ifosfamide—testicular cancer	0.000936	0.000936	CcSEcCtD
Naratriptan—Dyspnoea—Etoposide—testicular cancer	0.000932	0.000932	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Naratriptan—Somnolence—Etoposide—testicular cancer	0.000929	0.000929	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—testicular cancer	0.000924	0.000924	CcSEcCtD
Naratriptan—Nausea—Bleomycin—testicular cancer	0.00092	0.00092	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—testicular cancer	0.000919	0.000919	CcSEcCtD
Naratriptan—Vomiting—Dactinomycin—testicular cancer	0.000918	0.000918	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—testicular cancer	0.000917	0.000917	CcSEcCtD
Naratriptan—Rash—Dactinomycin—testicular cancer	0.000911	0.000911	CcSEcCtD
Naratriptan—Diarrhoea—Ifosfamide—testicular cancer	0.000905	0.000905	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Etoposide—testicular cancer	0.000902	0.000902	CcSEcCtD
Naratriptan—Body temperature increased—Cisplatin—testicular cancer	0.000902	0.000902	CcSEcCtD
Naratriptan—Fatigue—Etoposide—testicular cancer	0.000901	0.000901	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Naratriptan—Pain—Etoposide—testicular cancer	0.000894	0.000894	CcSEcCtD
Naratriptan—Constipation—Etoposide—testicular cancer	0.000894	0.000894	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—testicular cancer	0.000886	0.000886	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—testicular cancer	0.000881	0.000881	CcSEcCtD
Naratriptan—Sweating—Epirubicin—testicular cancer	0.000881	0.000881	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—testicular cancer	0.000881	0.000881	CcSEcCtD
Naratriptan—Dizziness—Ifosfamide—testicular cancer	0.000875	0.000875	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—testicular cancer	0.000862	0.000862	CcSEcCtD
Naratriptan—Feeling abnormal—Etoposide—testicular cancer	0.000861	0.000861	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—testicular cancer	0.00086	0.00086	CcSEcCtD
Naratriptan—Nausea—Dactinomycin—testicular cancer	0.000858	0.000858	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—testicular cancer	0.000855	0.000855	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—testicular cancer	0.00085	0.00085	CcSEcCtD
Naratriptan—Vomiting—Ifosfamide—testicular cancer	0.000841	0.000841	CcSEcCtD
Naratriptan—Hypersensitivity—Cisplatin—testicular cancer	0.000841	0.000841	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—testicular cancer	0.00084	0.00084	CcSEcCtD
Naratriptan—Rash—Ifosfamide—testicular cancer	0.000834	0.000834	CcSEcCtD
Naratriptan—Dermatitis—Ifosfamide—testicular cancer	0.000834	0.000834	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000833	0.000833	CcSEcCtD
Naratriptan—Urticaria—Etoposide—testicular cancer	0.00083	0.00083	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—testicular cancer	0.000829	0.000829	CcSEcCtD
Naratriptan—Body temperature increased—Etoposide—testicular cancer	0.000826	0.000826	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—testicular cancer	0.000822	0.000822	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—testicular cancer	0.000821	0.000821	CcSEcCtD
Naratriptan—Asthenia—Cisplatin—testicular cancer	0.000819	0.000819	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—testicular cancer	0.000818	0.000818	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—testicular cancer	0.000815	0.000815	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—testicular cancer	0.0008	0.0008	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—testicular cancer	0.000796	0.000796	CcSEcCtD
Naratriptan—Chills—Methotrexate—testicular cancer	0.000791	0.000791	CcSEcCtD
Naratriptan—Nausea—Ifosfamide—testicular cancer	0.000786	0.000786	CcSEcCtD
Naratriptan—Diarrhoea—Cisplatin—testicular cancer	0.000781	0.000781	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—testicular cancer	0.000779	0.000779	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—testicular cancer	0.000777	0.000777	CcSEcCtD
Naratriptan—Hypersensitivity—Etoposide—testicular cancer	0.00077	0.00077	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—testicular cancer	0.000769	0.000769	CcSEcCtD
Naratriptan—Erythema—Methotrexate—testicular cancer	0.000767	0.000767	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—testicular cancer	0.000767	0.000767	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—testicular cancer	0.000765	0.000765	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—testicular cancer	0.000759	0.000759	CcSEcCtD
Naratriptan—Asthenia—Etoposide—testicular cancer	0.00075	0.00075	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—testicular cancer	0.000745	0.000745	CcSEcCtD
Naratriptan—Chills—Epirubicin—testicular cancer	0.00074	0.00074	CcSEcCtD
Naratriptan—Pruritus—Etoposide—testicular cancer	0.000739	0.000739	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—testicular cancer	0.000737	0.000737	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—testicular cancer	0.000729	0.000729	CcSEcCtD
Naratriptan—Vomiting—Cisplatin—testicular cancer	0.000725	0.000725	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—testicular cancer	0.000723	0.000723	CcSEcCtD
Naratriptan—Rash—Cisplatin—testicular cancer	0.000719	0.000719	CcSEcCtD
Naratriptan—Dermatitis—Cisplatin—testicular cancer	0.000719	0.000719	CcSEcCtD
Naratriptan—Erythema—Epirubicin—testicular cancer	0.000718	0.000718	CcSEcCtD
Naratriptan—Diarrhoea—Etoposide—testicular cancer	0.000715	0.000715	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—testicular cancer	0.000712	0.000712	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—testicular cancer	0.000709	0.000709	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Naratriptan—Malaise—Methotrexate—testicular cancer	0.000692	0.000692	CcSEcCtD
Naratriptan—Dizziness—Etoposide—testicular cancer	0.000691	0.000691	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—testicular cancer	0.00069	0.00069	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—testicular cancer	0.000689	0.000689	CcSEcCtD
Naratriptan—Chills—Doxorubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Naratriptan—Nausea—Cisplatin—testicular cancer	0.000678	0.000678	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—testicular cancer	0.000674	0.000674	CcSEcCtD
Naratriptan—Cough—Methotrexate—testicular cancer	0.000669	0.000669	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—testicular cancer	0.000665	0.000665	CcSEcCtD
Naratriptan—Vomiting—Etoposide—testicular cancer	0.000665	0.000665	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Naratriptan—Agitation—Epirubicin—testicular cancer	0.00066	0.00066	CcSEcCtD
Naratriptan—Rash—Etoposide—testicular cancer	0.000659	0.000659	CcSEcCtD
Naratriptan—Dermatitis—Etoposide—testicular cancer	0.000658	0.000658	CcSEcCtD
Naratriptan—Headache—Etoposide—testicular cancer	0.000655	0.000655	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—testicular cancer	0.000653	0.000653	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—testicular cancer	0.000653	0.000653	CcSEcCtD
Naratriptan—Malaise—Epirubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—testicular cancer	0.000645	0.000645	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Naratriptan—Syncope—Epirubicin—testicular cancer	0.000644	0.000644	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—testicular cancer	0.000639	0.000639	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—testicular cancer	0.000631	0.000631	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Naratriptan—Cough—Epirubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—testicular cancer	0.000626	0.000626	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—testicular cancer	0.000622	0.000622	CcSEcCtD
Naratriptan—Infection—Methotrexate—testicular cancer	0.000622	0.000622	CcSEcCtD
Naratriptan—Nausea—Etoposide—testicular cancer	0.000621	0.000621	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—testicular cancer	0.000614	0.000614	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—testicular cancer	0.000613	0.000613	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—testicular cancer	0.000611	0.000611	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—testicular cancer	0.000611	0.000611	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—testicular cancer	0.000609	0.000609	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—testicular cancer	0.000608	0.000608	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—testicular cancer	0.000605	0.000605	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—testicular cancer	0.000587	0.000587	CcSEcCtD
Naratriptan—Oedema—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—testicular cancer	0.000585	0.000585	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—testicular cancer	0.000584	0.000584	CcSEcCtD
Naratriptan—Infection—Epirubicin—testicular cancer	0.000582	0.000582	CcSEcCtD
Naratriptan—Cough—Doxorubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Naratriptan—Shock—Epirubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—testicular cancer	0.000576	0.000576	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—testicular cancer	0.000575	0.000575	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00057	0.00057	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—testicular cancer	0.000558	0.000558	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—testicular cancer	0.000557	0.000557	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—testicular cancer	0.000547	0.000547	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—testicular cancer	0.000547	0.000547	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000541	0.000541	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—testicular cancer	0.00054	0.00054	CcSEcCtD
Naratriptan—Infection—Doxorubicin—testicular cancer	0.000539	0.000539	CcSEcCtD
Naratriptan—Pain—Methotrexate—testicular cancer	0.000535	0.000535	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Naratriptan—Shock—Doxorubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—testicular cancer	0.000527	0.000527	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—testicular cancer	0.000524	0.000524	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—testicular cancer	0.000516	0.000516	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—testicular cancer	0.000507	0.000507	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000506	0.000506	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Naratriptan—Pain—Epirubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Naratriptan—Constipation—Epirubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—testicular cancer	0.000497	0.000497	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—testicular cancer	0.000495	0.000495	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—testicular cancer	0.000482	0.000482	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—testicular cancer	0.000467	0.000467	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Naratriptan—Pain—Doxorubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—testicular cancer	0.000463	0.000463	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—testicular cancer	0.000461	0.000461	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—testicular cancer	0.000449	0.000449	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—testicular cancer	0.000443	0.000443	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—testicular cancer	0.000431	0.000431	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—testicular cancer	0.000429	0.000429	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—testicular cancer	0.000428	0.000428	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—testicular cancer	0.000415	0.000415	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—testicular cancer	0.000414	0.000414	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—testicular cancer	0.000401	0.000401	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—testicular cancer	0.000399	0.000399	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—testicular cancer	0.000398	0.000398	CcSEcCtD
Naratriptan—Rash—Methotrexate—testicular cancer	0.000395	0.000395	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—testicular cancer	0.000394	0.000394	CcSEcCtD
Naratriptan—Headache—Methotrexate—testicular cancer	0.000392	0.000392	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—testicular cancer	0.000389	0.000389	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—testicular cancer	0.000387	0.000387	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—testicular cancer	0.000384	0.000384	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—testicular cancer	0.000373	0.000373	CcSEcCtD
Naratriptan—Nausea—Methotrexate—testicular cancer	0.000372	0.000372	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—testicular cancer	0.000371	0.000371	CcSEcCtD
Naratriptan—Rash—Epirubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Naratriptan—Headache—Epirubicin—testicular cancer	0.000367	0.000367	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—testicular cancer	0.000358	0.000358	CcSEcCtD
Naratriptan—Nausea—Epirubicin—testicular cancer	0.000348	0.000348	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Naratriptan—Rash—Doxorubicin—testicular cancer	0.000342	0.000342	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Naratriptan—Headache—Doxorubicin—testicular cancer	0.00034	0.00034	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—testicular cancer	0.000322	0.000322	CcSEcCtD
